144 related articles for article (PubMed ID: 9855063)
1. 5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T; Wiechowska-Kozlowska A; Marlicz K; Bromley M; Roberts SA; Lawniczak M; Kolodziej B; Zyluk A; Stern PL
Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):479-84. PubMed ID: 9855063
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal antigen 5T4 expression as a prognostic factor in patients with gastric cancer.
Naganuma H; Kono K; Mori Y; Takayoshi S; Stern PL; Tasaka K; Matsumoto Y
Anticancer Res; 2002; 22(2B):1033-8. PubMed ID: 12168897
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma.
Starzynska T; Marsh PJ; Schofield PF; Roberts SA; Myers KA; Stern PL
Br J Cancer; 1994 May; 69(5):899-902. PubMed ID: 8180020
[TBL] [Abstract][Full Text] [Related]
4. The expression of 5T4 antigen in colorectal and gastric carcinoma.
Starzynska T; Rahi V; Stern PL
Br J Cancer; 1992 Nov; 66(5):867-9. PubMed ID: 1419629
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
Deveci MS; Deveci G
Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
[TBL] [Abstract][Full Text] [Related]
6. The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa.
Ali A; Langdon J; Stern P; Partridge M
Oral Oncol; 2001 Jan; 37(1):57-64. PubMed ID: 11120484
[TBL] [Abstract][Full Text] [Related]
7. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
10. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
Müller W; Schneiders A; Hommel G; Gabbert HE
Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
[TBL] [Abstract][Full Text] [Related]
11. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic evaluation of CDw75 antigen expression in patients with gastric carcinoma.
Elpek GO; Gelen T; Karpuzoğlu G; Karpuzoğlu T; Keles N
J Pathol; 2001 Feb; 193(2):169-74. PubMed ID: 11180162
[TBL] [Abstract][Full Text] [Related]
13. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
Fan Z; Li J; Dong B; Huang X
Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
[TBL] [Abstract][Full Text] [Related]
14. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
15. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.
Fukuda K; Tsujitani S; Maeta Y; Yamaguchi K; Ikeguchi M; Kaibara N
Gastric Cancer; 2002; 5(4):220-7. PubMed ID: 12491080
[TBL] [Abstract][Full Text] [Related]
16. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
Castro FV; McGinn OJ; Krishnan S; Marinov G; Li J; Rutkowski AJ; Elkord E; Burt DJ; Holland M; Vaghjiani R; Gallego A; Saha V; Stern PL
Leukemia; 2012 Jul; 26(7):1487-98. PubMed ID: 22266911
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
[TBL] [Abstract][Full Text] [Related]
18. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis.
Nagashima H; Mori M; Sadanaga N; Mashino K; Yoshikawa Y; Sugimachi K
Int J Oncol; 2001 Jun; 18(6):1157-62. PubMed ID: 11351245
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
